HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lingxiao Xing Selected Research

Astrocytoma (Pilocytic Astrocytoma)

8/2020Expression, association with clinicopathological features and prognostic potential of CEP55, p-Akt, FoxM1 and MMP-2 in astrocytoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lingxiao Xing Research Topics

Disease

17Neoplasms (Cancer)
04/2021 - 03/2009
9Lung Neoplasms (Lung Cancer)
12/2020 - 03/2009
9Carcinogenesis
10/2020 - 09/2012
8Adenocarcinoma of Lung
02/2021 - 12/2010
8Adenocarcinoma
02/2021 - 01/2004
5Inflammation (Inflammations)
10/2020 - 02/2015
4Pneumonia (Pneumonitis)
01/2019 - 02/2015
3Esophageal Squamous Cell Carcinoma
01/2020 - 03/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014 - 08/2010
2Carcinoma (Carcinomatosis)
03/2013 - 07/2009
2Infections
03/2013 - 04/2012
1Squamous Cell Carcinoma of Head and Neck
06/2021
1Astrocytoma (Pilocytic Astrocytoma)
08/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2015
1Esophageal Neoplasms (Esophageal Cancer)
11/2015
1Solitary Pulmonary Nodule
01/2015
1Chromosome Aberrations (Chromosome Abnormalities)
01/2015
1Neoplasm Metastasis (Metastasis)
10/2014
1Lymphatic Metastasis
10/2014
1Genomic Instability
04/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2013
1Stomach Neoplasms (Stomach Cancer)
04/2012

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
02/2021 - 01/2014
5aflatoxin G1IBA
01/2019 - 09/2012
5MicroRNAs (MicroRNA)IBA
08/2017 - 08/2010
3Long Noncoding RNAIBA
06/2021 - 09/2019
2ErbB Receptors (EGF Receptor)IBA
02/2021 - 12/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 01/2019
2Biological ProductsIBA
08/2020 - 01/2004
2Proteins (Proteins, Gene)FDA Link
08/2020 - 04/2014
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 10/2019
2AflatoxinsIBA
11/2017 - 02/2015
2CarcinogensIBA
11/2015 - 01/2015
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 04/2014
2Pepsinogen A (Pepsinogen)IBA
03/2013 - 04/2012
1Cyclic PeptidesIBA
04/2021
1major vault proteinIBA
02/2021
1Gefitinib (Iressa)FDA Link
02/2021
1Y-Box-Binding Protein 1IBA
02/2021
1Tyrosine Kinase InhibitorsIBA
02/2021
1RNA (Ribonucleic Acid)IBA
12/2020
1Antisense RNA (Anti-Sense RNA)IBA
12/2020
1HMGB1 Protein (HMG1)IBA
10/2020
1DNA-Binding Proteins (DNA Binding Protein)IBA
10/2020
1Forkhead Box Protein M1IBA
08/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2020
1Urethane (Ethyl Carbamate)IBA
01/2020
1Proto-Oncogene Proteins c-etsIBA
01/2020
1Benzo(a)pyreneIBA
01/2019
1SmokeIBA
01/2019
1Matrix Metalloproteinases (MMPs)IBA
11/2017
1Interleukin-6 (Interleukin 6)IBA
11/2017
1Superoxide DismutaseIBA
11/2017
1VimentinIBA
11/2017
1AntioxidantsIBA
03/2016
1Acetylcysteine (Siran)FDA LinkGeneric
03/2016
1Phosphotransferases (Kinase)IBA
12/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2015
1tyrosine receptor (receptor, tyrosine)IBA
12/2015
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2015
1MycotoxinsIBA
11/2015
1SterigmatocystinIBA
11/2015
1Small Nucleolar RNA (snoRNA)IBA
03/2015
1Peptide Initiation Factors (Initiation Factor)IBA
10/2014
1Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA
10/2014
1LuciferasesIBA
10/2014
1Formaldehyde (Formol)FDA Link
10/2014
1ParaffinIBA
10/2014
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2014
1ochratoxin AIBA
10/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2013
1PepsinogensIBA
03/2013
1Aflatoxin B1 (Aflatoxin B)IBA
09/2012
1Immunoglobulin G (IgG)IBA
04/2012
1deoxynivalenolIBA
07/2009
1Aldehyde Dehydrogenase 1 FamilyIBA
03/2009
1Caspase 3 (Caspase-3)IBA
01/2005
1CalciumIBA
01/2005

Therapy/Procedure

2Oral Administration
10/2020 - 02/2015
2Drug Therapy (Chemotherapy)
10/2019 - 03/2009
1Immunotherapy
04/2021
1Therapeutics
08/2010